HealthLynked (HLYK) EBIT Margin (2016 - 2026)

HealthLynked has disclosed EBIT Margin across 11 years of filings, most recently posting 189.07% for Q1 2026.

• In Q1 2026, EBIT Margin fell 6877.0% year-over-year to 189.07%; the TTM figure through Mar 2026 stood at 172.38% (down 13492.0% YoY), while the FY2025 annual figure was 33.36%, up 944.0% from the prior year.
• EBIT Margin climbed to 189.07% in Q1 2026, from 237.12% in the prior quarter.
• Over the last five years, EBIT Margin for HLYK reached as high as 426.75% in Q4 2024 and fell as low as 295.1% in Q4 2022.
• The 5-year median for EBIT Margin is 115.26% (2025), against an average of 86.13%.
• Annual changes were most pronounced in 2023 — EBIT Margin surged 59868 bps — and 2025, when it sank 66387 bps.
• A 5-year view of EBIT Margin shows it stood at 295.1% in 2022, then soared by 203 bps to 303.58% in 2023, then soared by 41 bps to 426.75% in 2024, then plunged by 156 bps to 237.12% in 2025, then rose by 20 bps to 189.07% in 2026.
• According to Business Quant data, EBIT Margin over the past three periods registered 189.07%, 237.12%, and 189.59% for Q1 2026, Q4 2025, and Q3 2025 respectively.